Merck MRK
NYSE MRK
$147.53 -0.93 (-0.63%)
As of: Sep 9, 2026 · 3:59 PM EDT

Merck (MRK) Construction in Progress (2009 - 2025)

Merck's (MRK) quarterly Construction in Progress came in at $9.2 billion in Q4 2025, up 14.8% year-over-year from $8.0 billion in Q4 2024, and up 14.8% quarter-over-quarter from $8.0 billion in Q4 2024.

Analysis

Merck (MRK) Construction in Progress (2009 - 2025) Analysis & Trends

Merck (MRK) has reported Construction in Progress for 17 consecutive years, with $9.2 billion the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Construction in Progress rose 14.8% year-over-year to $9.2 billion in Q4 2025; TTM through Dec 2025 was $9.2 billion, a 14.8% increase from a year earlier, with the FY2025 full-year figure at $9.2 billion, up 14.8% from the prior year.
  • Construction in Progress was $9.2 billion for Q4 2025 at Merck, up from $8.0 billion in the prior quarter.
  • Over five years, Construction in Progress peaked at $9.2 billion in Q4 2022 and troughed at $8.0 billion in Q4 2024.
  • A 5-year average of $8.6 billion and a median of $8.3 billion in 2021 frame the typical range for Construction in Progress.
  • Across the five-year window, Construction in Progress increased 19.3% in 2021 and fell 10.06% in 2023, its largest moves.
  • Over 5 years, Construction in Progress stood at $8.3 billion in 2021, then grew by 10.5% to $9.2 billion in 2022, then fell by 10.06% to $8.3 billion in 2023, then fell by 3.36% to $8.0 billion in 2024, then grew by 14.8% to $9.2 billion in 2025.
  • The last three Construction in Progress figures came in at $9.2 billion (Q4 2025), $8.0 billion (Q4 2024), and $8.3 billion (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn -
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn -
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn -
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn -
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn -
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn -
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn -
10 Jazz Pharmaceuticals 16.02 Bn 14.40 Bn 1.09 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 9.17 Bn
Dec 31, 2024 7.98 Bn
Dec 31, 2023 8.26 Bn
Dec 31, 2022 9.19 Bn
Dec 31, 2021 8.31 Bn
Dec 31, 2020 6.97 Bn
Dec 31, 2019 5.01 Bn
Dec 31, 2018 3.36 Bn
Dec 31, 2017 2.30 Bn
Dec 31, 2016 1.87 Bn
Dec 31, 2015 1.53 Bn
Dec 31, 2014 1.45 Bn
Dec 31, 2013 1.81 Bn
Dec 31, 2012 2.44 Bn
Dec 31, 2011 2.20 Bn
Dec 31, 2010 2.07 Bn
Dec 31, 2009 1.82 Bn